These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 24081864)

  • 21. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    Evans M; Carrero JJ; Szummer K; Åkerblom A; Edfors R; Spaak J; Jacobson SH; Andell P; Lindhagen L; Jernberg T
    J Am Coll Cardiol; 2016 Apr; 67(14):1687-97. PubMed ID: 27056774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
    Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction.
    Kane JA; Kim JK; Haidry SA; Salciccioli L; Lazar J
    Cardiology; 2017; 137(2):121-125. PubMed ID: 28376504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin axis blockade, acute kidney injury, and perioperative morbidity in patients undergoing colorectal surgery: A retrospective cohort study.
    Bonavia A; Javaherian M; Skojec AJ; Chinchilli VM; Mets B; Karamchandani K
    Medicine (Baltimore); 2019 Aug; 98(33):e16872. PubMed ID: 31415426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-angiotensin system blocker use and the risk of acute kidney injury after colorectal cancer surgery: a population-based cohort study.
    Slagelse C; Gammelager H; Iversen LH; Liu KD; Sørensen HTT; Christiansen CF
    BMJ Open; 2019 Nov; 9(11):e032964. PubMed ID: 31753901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis.
    Whiting P; Morden A; Tomlinson LA; Caskey F; Blakeman T; Tomson C; Stone T; Richards A; Savović J; Horwood J
    BMJ Open; 2017 Apr; 7(4):e012674. PubMed ID: 28389482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
    Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery.
    Yang SY; Huang TM; Lai TS; Chou NK; Tsao CH; Huang YP; Lin SL; Chen YM; Wu VC; Nsarf Study Group
    Front Pharmacol; 2021; 12():662301. PubMed ID: 33967804
    [No Abstract]   [Full Text] [Related]  

  • 29. Perioperative management of patients treated with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a quality improvement audit.
    Vijay A; Grover A; Coulson TG; Myles PS
    Anaesth Intensive Care; 2016 May; 44(3):346-52. PubMed ID: 27246933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative treatment with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker has no beneficial effect on the development of new-onset atrial fibrillation after off-pump coronary artery bypass graft surgery.
    Chin JH; Lee EH; Son HJ; Kim WJ; Choi DK; Park SK; Sim JY; Choi IC; Hahm KD
    Clin Cardiol; 2012 Jan; 35(1):37-42. PubMed ID: 22020954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers on the day of surgery on myocardial injury after non-cardiac surgery: A retrospective cohort study.
    Kim J; Lee S; Choi J; Ryu DK; Woo S; Park M
    J Clin Anesth; 2024 Jun; 94():111401. PubMed ID: 38330844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Submaximal Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Dosing Among Persons With Proteinuria.
    Chu CD; Powe NR; Estrella MM; Shlipak MG; McCoy IE; Tuot DS
    Mayo Clin Proc; 2022 Nov; 97(11):2099-2106. PubMed ID: 36210196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies.
    Yacoub R; Patel N; Lohr JW; Rajagopalan S; Nader N; Arora P
    Am J Kidney Dis; 2013 Dec; 62(6):1077-86. PubMed ID: 23791246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre- and/or Intra-Operative Prescription of Diuretics, but Not Renin-Angiotensin-System Inhibitors, Is Significantly Associated with Acute Kidney Injury after Non-Cardiac Surgery: A Retrospective Cohort Study.
    Tagawa M; Ogata A; Hamano T
    PLoS One; 2015; 10(7):e0132507. PubMed ID: 26146836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Type 1 Cardiorenal Syndrome.
    Ilges DT; Dermody ML; Blankenship C; Mansfield V; Van Tuyl JS
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):611-618. PubMed ID: 34138673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Statin and Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults With Human Immunodeficiency Virus Infection.
    Erlandson KM; Kitch D; Wester CW; Kalayjian RC; Overton ET; Castillo-Mancilla J; Koletar SL; Benson CA; Campbell TB; Robertson K; Lok JJ
    Clin Infect Dis; 2017 Nov; 65(12):2042-2049. PubMed ID: 29020174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study : ACEI/ARB and vascular calcification.
    Takaori K; Iwatani H; Yamato M; Ito T
    BMC Nephrol; 2021 Jan; 22(1):7. PubMed ID: 33407242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments.
    Hirai T; Yamaga R; Fujita A; Itoh T
    J Clin Pharm Ther; 2018 Dec; 43(6):829-835. PubMed ID: 29908131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil Gelatinase-associated Lipocalin as a Marker of Postoperative Acute Kidney Injury Following Cardiac Surgery in Patients with Preoperative Kidney Impairment.
    Tidbury N; Browning N; Shaw M; Morgan M; Kemp I; Matata B
    Cardiovasc Hematol Disord Drug Targets; 2019; 19(3):239-248. PubMed ID: 30987577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.